Stem Cells International · 2019 · 154 citations · 25 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationInflammationCytokine BiologyImmune Cell DifferentiationInflammatory SignalingMacrophage BiologyT Cell ActivationT Cell BiologyAnti-inflammatory MechanismsImmunomodulatory CytokinesImmunomodulatory EffectsM2 Macrophage PhenotypesM2-like Macrophage ActivationMacrophage ImmunomodulationMacrophage PolarizationMonocyte-derived Macrophages
Accumulating evidence has shown that the paracrine factors derived from mesenchymal stem cells (MSCs) are capable of regulating the immune system via interaction with various immune cells. In this study, adipose-derived MSCs (AdMSCs) and human peripheral blood monocytes (PBMCs) were isolated and cultured to examine the effects of MSC-induced macrophages (iM Φ ) on inflammation and immune modulation. Indirect coculture with MSCs increased the expression of arginase-1 and mannose receptor (CD206), markers of activated M2 macrophages, in the PBMCs demonstrating that MSC-secreted factors promoted M2-M Φ polarization. Additionally, iM Φ exhibited a similar higher inhibitory effect on the growth of activated T cells compared to that in the other groups (AdMSCs only, AdMSCs plus iM Φ ), implying that iM Φ can play a sufficient functional role. Interestingly, the population of FoxP3 Treg cells significantly increased when cocultured with iM Φ , suggesting that iM Φ have an immunomodulatory effect on the Treg cells through the modulation of the FoxP3 expression. Notably, iM Φ expressed high levels of immunosuppressive and anti-inflammatory cytokines, namely IL-10 and TSG-6. Furthermore, we confirmed that the AdMSC-derived exosomes modulated macrophage polarization by upregulating the expression of M2 macrophage markers. Conclusively, our results suggest that iM Φ play a significant role in regulating the immunomodulatory- and inflammatory-mediated responses. Thus, iM Φ may be used as a novel stem cell-based cell-free therapy for the treatment of immune-mediated inflammatory disorders.
25